Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008:2:78-81.
doi: 10.2174/1874613600802010078. Epub 2008 Nov 5.

Harnessing pharmacogenomics to tackle resistance to the "nucleoside reverse trancripatse inhibitor" backbone of highly active antiretroviral therapy in resource limited settings

Misaki Wayengera  1 , Henry Kajumbula, Wilson Byarugaba
Affiliations

Harnessing pharmacogenomics to tackle resistance to the "nucleoside reverse trancripatse inhibitor" backbone of highly active antiretroviral therapy in resource limited settings

Misaki Wayengera et al. Open AIDS J. 2008.

Abstract

Background: The sustainable use of HAART within the sub-Saharan and other developing world settings faces the emerging challenge of drug resistance. Nucleoside reverse transcriptase inhibitors (NRTI) form the backbone of HAART and preserving their "antiviral efficacy" is thus critical to sustainable HAART use.

Methods: A systematic review of the "mechanisms of evolution" of resistance to NRTI at the HIV genome level, and the phenotypic manifestations on drug pharmacokinetics was done.

Conclusion: This paper provides an evidence based account of how the knowledge of pharmacogenomics may be exploited to tackle NRTI resistance within limited resource.

Keywords: Acquired immunodeficiency syndrome (AIDS); drug resistance.; highly active antiretroviral therapy (HAART); human immunodeficiency virus (HIV).

PubMed Disclaimer

References

    1. UNAIDS. Report on the global HIV-AIDS epidemic:Geneva. 2007.
    1. Attaran A. Adherence to HAART: Africans Take Medicines More Faithfully than North Americans. PLoS Med. 2007;4(2):e83. - PMC - PubMed
    1. World Health Organization & Joint United Nations Programmed on HIV/AIDS (UNAIDS) Progress on global access to HIV antiretroviral therapy: a report on "3 by 5" and beyond Geneva, Switzerland: World Health Organization, Joint United Nations Programme on HIV/AIDS (UNAIDS) Available from: http://www.who.int/hiv/fullreport_en_ highres.pdf . [Internet: Accessed 12th Dec 2007].
    1. Office of Global AIDS Coordinator U.S. President's Emergency Plan for AIDS Relief Making a difference: supporting antiretroviral treatment Washington DC:Office of Global AIDS Coordinator. Available from: http:/ /www.state.gov/documents/organization/67502.pdf . [Internet: Accessed 12th Dec 2007].
    1. Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–90. - PubMed

LinkOut - more resources